Home/Filings/4/0001493152-18-009946
4//SEC Filing

Emerson Erik 4

Accession 0001493152-18-009946

CIK 0000737207other

Filed

Jul 11, 8:00 PM ET

Accepted

Jul 12, 5:00 PM ET

Size

6.1 KB

Accession

0001493152-18-009946

Insider Transaction Report

Form 4
Period: 2018-07-10
Emerson Erik C.
Chief Commercial Officer
Transactions
  • Award

    Options to purchase common stock

    2018-07-10+1,125,0001,125,000 total
    Exercise: $0.66Exp: 2028-07-10common stock (1,125,000 underlying)
Footnotes (1)
  • [F1]Options to purchase 187,500 shares of common stock are exercisable immediately, options to purchase 187,500 shares of common stock are exercisable on each of July 10, 2019, July 10, 2020 and July 10, 2021, options to purchase 187,500 shares of common stock shall vest on such date, if any, as the Issuer determines that it has achieved net product revenue in the amount of not less than $1.2 million for the portion of the 2018 fiscal year following June 18, 2018, and options to purchase 187,500 shares of common stock shall vest on such date, if any, as the Issuer determines that the daily VWAP of the common stock of the Issuer was not less than $2.00 per share for a sixty consecutive day period beginning on any calendar day during the 2018 fiscal year on or after June 18, 2018.

Documents

1 file

Issuer

Marina Biotech, Inc.

CIK 0000737207

Entity typeother

Related Parties

1
  • filerCIK 0001710496

Filing Metadata

Form type
4
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 5:00 PM ET
Size
6.1 KB